Law and research could add up to profitable niche drugs

Burkhard Haefner
Additional contact information
Burkhard Haefner: Johnson & Johnson Pharma Research and Development, Turnhoutseweg 30, Box 6423

Nature, 2007, vol. 446, issue 7138, 856-856

Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/446856b Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:446:y:2007:i:7138:d:10.1038_446856b

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/446856b

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().